Clinical features and sera anti-aquaporin 4 antibody positivity in patients with demyelinating disorders of the central nervous system from Tianjin, China
- PMID: 23890015
- PMCID: PMC6492993
- DOI: 10.1111/cns.12156
Clinical features and sera anti-aquaporin 4 antibody positivity in patients with demyelinating disorders of the central nervous system from Tianjin, China
Abstract
Aims: To investigate the clinical characteristics and sera anti-aquaporin 4 (AQP4) antibody positivity in patients with inflammatory demyelinating disorders (IDDs) of the central nervous system (CNS) in Tianjin, China.
Methods: We retrospectively evaluated 234 patients with IDDs including neuromyelitis optica (NMO), recurrent optic neuritis (rON), longitudinally extensive transverse myelitis (LETM), clinically isolated syndrome (CIS), and multiple sclerosis (MS) groups. Sera from 217 patients were determined for AQP4-Ab. The clinical characteristics and sera anti-AQP4 positivity were compared.
Results: The IDDS comprised 63 MS, 51 NMO, 56 LETM, 10 rON, and 54 CIS. Compared with MS, NMO had a higher frequency of occurrence in women, intractable hiccup and nausea (IHN), medullospinal lesion, longitudinally extensive spinal cord lesions (LESCL) and bilateral ON, disease onset at a later age, and worsening residual disability. AQP4-Ab-positive rates were 84.1% and 69% in NMO and NMO spectrum disorders (NMOSD), respectively, whereas it was undetectable in all of the MS sera samples.
Conclusions: We comprehensively contrast the distinct clinical features of MS, NMO, and NMOSD in our center. A sensitive AQP4-Ab assay is necessary for the early diagnosis of NMOSD in our patients. Neither medullospinal lesion nor IHN is unique in NMO.
Keywords: Anti-aquaporin 4 antibody; Chinese; Clinical features; Multiple sclerosis; Neuromyelitis optica.
© 2013 John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.J Neuroimmunol. 2013 Sep 15;262(1-2):100-5. doi: 10.1016/j.jneuroim.2013.06.004. Epub 2013 Jul 6. J Neuroimmunol. 2013. PMID: 23838529
-
[The correlation factor analysis for conversion of clinically isolated syndrome to multiple sclerosis and neuromyelitis optica].Zhonghua Nei Ke Za Zhi. 2016 Jun;55(6):460-5. doi: 10.3760/cma.j.issn.0578-1426.2016.06.012. Zhonghua Nei Ke Za Zhi. 2016. PMID: 27256609 Chinese.
-
[Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].Zhonghua Yi Xue Za Zhi. 2012 Nov 20;92(43):3032-5. Zhonghua Yi Xue Za Zhi. 2012. PMID: 23328372 Chinese.
-
[AQP4 immunohistochemistry in neuromyelitis optica and multiple sclerosis: a neuropathological review].Brain Nerve. 2010 Sep;62(9):961-74. Brain Nerve. 2010. PMID: 20844307 Review. Japanese.
-
[Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].Rinsho Shinkeigaku. 2010 Nov;50(11):788-93. doi: 10.5692/clinicalneurol.50.788. Rinsho Shinkeigaku. 2010. PMID: 21921443 Review. Japanese.
Cited by
-
Normal-Appearing Cerebellar Damage in Neuromyelitis Optica Spectrum Disorder.AJNR Am J Neuroradiol. 2019 Jul;40(7):1156-1161. doi: 10.3174/ajnr.A6098. Epub 2019 Jun 20. AJNR Am J Neuroradiol. 2019. PMID: 31221630 Free PMC article.
-
Relapse of neuromyelitis optica associated with oral progestin.J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):788-789. doi: 10.1136/jnnp-2017-316356. Epub 2017 Oct 9. J Neurol Neurosurg Psychiatry. 2018. PMID: 28993474 Free PMC article. No abstract available.
-
Recent progress in epidemiology, clinical features, and therapy of multiple sclerosis in China.Ther Adv Neurol Disord. 2023 Sep 15;16:17562864231193816. doi: 10.1177/17562864231193816. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 37719665 Free PMC article. Review.
-
The prevalence of anti-neurofascin-155 antibodies in patients with neuromyelitis optica spectrum disorders.Clin Exp Immunol. 2021 Oct;206(1):1-11. doi: 10.1111/cei.13617. Epub 2021 Jun 7. Clin Exp Immunol. 2021. PMID: 33998675 Free PMC article. Clinical Trial.
-
Increased serum IL-36β and IL-36γ levels in patients with neuromyelitis optica spectrum disorders: association with disease activity.BMC Neurol. 2019 Aug 5;19(1):185. doi: 10.1186/s12883-019-1415-2. BMC Neurol. 2019. PMID: 31382910 Free PMC article.
References
-
- Misu T, Fujihara K, Nakashima I, Sato S, Itoyama Y. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology 2005;65:1479–1482. - PubMed
-
- Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol 2003;2:117–127. - PubMed
-
- Osoegawa M, Kira J, Fukazawa T, et al. Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: Nationwide survey results over 30 years. Mult Scler 2009;15:159–173. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous